We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
-1.32%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$493M
AUM Growth
-$43.7M
(-8.1%)
Cap. Flow
-$6.65M
Cap. Flow
% of AUM
-1.35%
Top 10 Holdings %
Top 10 Hldgs %
14.21%
Holding
1,115
New
370
Increased
135
Reduced
155
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$15.8M |
| 2 |
Micron Technology
MU
|
+$9.79M |
| 3 |
Medtronic
MDT
|
+$7.24M |
| 4 |
Meta Platforms (Facebook)
META
|
+$6.64M |
| 5 |
Alibaba
BABA
|
+$5.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Truist Financial
TFC
|
+$6.76M |
| 2 |
Qualcomm
QCOM
|
+$6.11M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$4.04M |
| 4 |
EOG Resources
EOG
|
+$4.02M |
| 5 |
T-Mobile US
TMUS
|
+$3.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 13.66% |
| 3 | Consumer Discretionary | 12.3% |
| 4 | Industrials | 9.83% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Compass
COMP
$8.88B
| $50K | 0.01% |
+21,600
| New | +$76.7K |
|
627
Hudbay
HBM
$9.67B
| $48K | 0.01% |
11,870
-11,930
| -50% | -$47.8K |
|
628
Turkcell
TKC
$4.78B
| $47K | 0.01% |
17,857
+100
| +0.6% | +$274 |
|
|
HYZN
629
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $44K | 0.01% |
+514
| New | +$67.5K |
|
630
Cognyte Software
CGNT
$657M
| $42K | 0.01% |
+10,431
| New | +$49.5K |
|
631
Ocugen
OCGN
$420M
| $41K | 0.01% |
+23,000
| New | +$57.3K |
|
|
CORZ
632
DELISTED
Core Scientific, Inc. Common Stock
CORZ
| $41K | 0.01% |
+31,300
| New | +$66.6K |
|
|
CTEV
633
Claritev Corp
CTEV
$386M
| $39K | 0.01% |
343
-230
| -40% | -$38K |
|
634
Inter&Co
INTR
$2.47B
| $35K | 0.01% |
+10,655
| New | +$37.4K |
|
635
Grove Collaborative
GROV
$46.7M
| $28K | 0.01% |
+2,520
| New | +$61.7K |
|
|
ML
636
DELISTED
MoneyLion Inc.
ML
| $27K | 0.01% |
+1,023
| New | +$46.9K |
|
637
Rigel Pharmaceuticals
RIGL
$712M
| $25K | 0.01% |
+2,095
| New | +$28.3K |
|
|
AGEN
638
Agenus
AGEN
$275M
| $24K | ﹤0.01% |
586
-219
| -27% | -$11.2K |
|
639
Applied Digital
APLD
$7.61B
| $23K | ﹤0.01% |
+13,265
| New | +$25K |
|
|
NEUE
640
DELISTED
NeueHealth
NEUE
| $23K | ﹤0.01% |
278
-60
| -18% | -$7.96K |
|
641
Akebia Therapeutics
AKBA
$341M
| $22K | ﹤0.01% |
68,600
-235,500
| -77% | -$92.4K |
|
642
Sidus Space
SIDU
$172M
| $22K | ﹤0.01% |
+105
| New | +$31.6K |
|
643
Precigen
PGEN
$1.97B
| $21K | ﹤0.01% |
10,100
-5,500
| -35% | -$11.6K |
|
|
SOPA
644
DELISTED
Society Pass
SOPA
| $20K | ﹤0.01% |
847
-53
| -6% | -$1.51K |
|
|
CZOO
645
DELISTED
Cazoo Group Ltd
CZOO
| $18K | ﹤0.01% |
+20
| New | +$26.7K |
|
646
Kartoon Studios
TOON
$34.8M
| $17K | ﹤0.01% |
+2,820
| New | +$20.8K |
|
|
DS
647
DELISTED
Drive Shack Inc.
DS
| $17K | ﹤0.01% |
+27,400
| New | +$32.7K |
|
|
LTCH
648
DELISTED
Latch, Inc. Common Stock
LTCH
| $15K | ﹤0.01% |
15,400
-90,700
| -85% | -$104K |
|
|
AMTD
649
AMTD IDEA Group
AMTD
$71.4M
| $13K | ﹤0.01% |
+1,800
| New | +$20.7K |
|
650
Aquestive Therapeutics
AQST
$472M
| $12K | ﹤0.01% |
+10,235
| New | +$11.6K |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Bayesian Capital Management held 1,115 positions worth $493M, down 8.1% from $537M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Bayesian Capital Management's Q3 2022 filing shows 370 new, 135 increased, 155 reduced and 453 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 39,700 shares worth $14.2M. The largest sale was Truist Financial, an estimated $6.76M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Bayesian Capital Management's largest Q3 2022 buy was State Street SPDR S&P 500 ETF Trust: 39,700 shares worth $14.2M.
- Bayesian Capital Management added most to Medtronic in Q3 2022, an estimated $7.24M increase.
- Bayesian Capital Management's biggest Q3 2022 reduction was Truist Financial, cutting an estimated $6.76M.
- Bayesian Capital Management fully exited Walgreens Boots Alliance in Q3 2022, selling an estimated $4.04M.
- Bayesian Capital Management's ten largest holdings make up 14% of its $493M portfolio in Q3 2022.
- Bayesian Capital Management opened 370 new positions and closed 453 in Q3 2022.
- Bayesian Capital Management's portfolio value fell 8.1% quarter-over-quarter to $493M.
Based on Bayesian Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.